Interv Akut Kardiol. 2022;21(3):163-166

Tachycardia-induced cardiomyopathy in a patient with atrial fibrillation and arterial hypertension

©těpán Havránek
II. interní klinika kardiologie a angiologie 1. lékařské fakulty Univerzity Karlovy a Vąeobecné fakultní nemocnice v Praze

The case report presents a young hypertensive male patient with atrial fibrillation complicated with tachycardia-induced cardiomyopathy. Patient non-compliance was responsible for the recurrence of arrhythmia and heart failure symptoms. Catheter ablation of atrial fibrillation was an effective treatment option, and optimisation of pharmacotherapy was required to control blood pressure. A literature review is included.

Keywords: atrial fibrillation, arterial hypertension, tachycardia-induced cardiomyopathy.

Received: June 15, 2022; Accepted: July 21, 2022; Prepublished online: July 21, 2022; Published: November 21, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Havránek ©. Tachycardia-induced cardiomyopathy in a patient with atrial fibrillation and arterial hypertension. Interv Akut Kardiol. 2022;21(3):163-166.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Gopinathannair R, Etheridge SP, Marchlinski FE, et al. Arrhythmia­‑Induced Cardiomyopathies: Mechanisms, Recognition, and Management. J Am Coll Cardiol. 2015;66(15): 1714-28. Go to original source... Go to PubMed...
    2. Shinbane JS, Wood MA, Jensen DN, et al. Tachycardia­‑induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol. 1997;29(4):709-15. Go to original source... Go to PubMed...
    3. Campos B, Jauregui ME, Park KM, et al. New unipolar electrogram criteria to identify irreversibility of nonischemic left ventricular cardiomyopathy. J Am Coll Cardiol. 2012;60(21):2194-204. Go to original source... Go to PubMed...
    4. Nia AM, Gassanov N, Dahlem KM, et al. Diagnostic accuracy of NT­‑proBNP ratio (BNP­‑R) for early diagnosis of tachycardia­‑mediated cardiomyopathy: a pilot study. Clin Res Cardiol. 2011;100(10):887-96. Go to original source... Go to PubMed...
    5. Mont L, Bisbal F, Hernandez­‑Madrid A, et al. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study). Eur Heart J. 2014;35(8):501-7. Go to original source... Go to PubMed...
    6. Packer DL, Mark DB, Robb RA, et al. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA. 2019;321(13):1261-74. Go to original source... Go to PubMed...
    7. Marrouche NF, Brachmann J, Andresen D, et al. Catheter Ablation for Atrial Fibrillation with Heart Failure. N Engl J Med. 2018;378(5):417-27. Go to original source... Go to PubMed...
    8. Dagres N, Varounis C, Gaspar T, et al. Catheter ablation for atrial fibrillation in patients with left ventricular systolic dysfunction. A systematic review and meta­‑analysis. J Card Fail. 2011;17(11):964-70. Go to original source... Go to PubMed...
    9. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio­‑Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373-498. Go to original source... Go to PubMed...
    10. Prabhu S, Costello BT, Taylor AJ, et al. Regression of Diffuse Ventricular Fibrosis Following Restoration of Sinus Rhythm With Catheter Ablation in Patients With Atrial Fibrillation and Systolic Dysfunction: A Substudy of the CAMERA MRI Trial. JACC Clin Electrophysiol. 2018;4(8):999-1007. Go to original source... Go to PubMed...
    11. Halliday BP, Wassall R, Lota AS, et al. Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED­‑HF): an open­‑label, pilot, randomised trial. Lancet. 2019;393(10166):61-73. Go to original source... Go to PubMed...
    12. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-726. Go to original source... Go to PubMed...
    13. Lip GYH, Coca A, Kahan T, et al. Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia­‑Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). Europace. 2017;19(6):891-911. Go to original source... Go to PubMed...
    14. Steinberg JS, Shabanov V, Ponomarev D, et al. Effect of Renal Denervation and Catheter Ablation vs Catheter Ablation Alone on Atrial Fibrillation Recurrence Among Patients With Paroxysmal Atrial Fibrillation and Hypertension: The ERADICATE­‑AF Randomized Clinical Trial. JAMA. 2020;323(3):248-55. Go to original source... Go to PubMed...
    15. Dzeshka MS, Shantsila A, Shantsila E, et al. Atrial Fibrillation and Hypertension. Hypertension. 2017;70(5):854-61. Go to original source... Go to PubMed...
    16. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953-2041. Go to original source... Go to PubMed...
    17. Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta­‑analysis on 376,162 patients. Am J Med. 2012;125(9):882-7 e1. Go to original source... Go to PubMed...
    18. Simons LA, Chung E, Ortiz M. Long­‑term persistence with single­‑pill, fixed­‑dose combination therapy versus two pills of amlodipine and perindopril for hypertension: Australian experience. Curr Med Res Opin. 2017;33(10): 1783-7. Go to original source... Go to PubMed...
    19. Middeldorp ME, Pathak RK, Meredith M, et al. PREVEntion and regReSsive Effect of weight­‑loss and risk factor modification on Atrial Fibrillation: the REVERSE­‑AF study. Europace. 2018;20(12):1929-35. Go to original source... Go to PubMed...
    20. Pathak RK, Middeldorp ME, Meredith M, et al. Long­‑Term Effect of Goal­‑Directed Weight Management in an Atrial Fibrillation Cohort: A Long­‑Term Follow­‑Up Study (LEGACY). J Am Coll Cardiol. 2015;65(20):2159-69. Go to original source... Go to PubMed...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.